Financing, Equity Capital Markets

Cogent Biosciences

12/20
|
$115.0 Million
Piper Sandler served as bookrunner for Cognent Biosciences on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma